With the groundbreaking of the Berlin Center for Gene and Cell Therapies and the opening of the Berlin Center for Advanced Therapies at Charité, Berlin-Brandenburg is stepping up efforts to position itself as a leading location for advanced and…
An EU-funded research project coordinated by the Berlin Institute of Health at Charité (BIH) has uncovered how the pancreas develops, adapts, and changes in disease. The study has now been published in Cell Metabolism.
The German Stem Cell Network is honoring Maike Sander with a Hilde Mangold Award. The network recognized Sander for her scientific excellence, outstanding scientific leadership, and impact as a role model for women in research.
Researchers from Charité – Universitätsmedizin Berlin have gained new insights into the long-term effects of NMDA receptor encephalitis. In this section, first author Dr. Stephan Krohn and senior author Prof. Carsten Finke answer questions about…
- Milestone marks Kupando’s evolution from a research-focused organization to a clinical-stage biopharmaceutical company
- Phase 1 trial evaluates KUP101, a differentiated dual Toll-Like Receptor (TLR) 4/7 agonist designed to harness innate immunity…
- Combining complementary strengths
- A broader range of products for pharmacies from a single source
- A common foundation for reliable supply and growth in Germany and Europe
New vaccine and rapid test approach against the hospital fungus Candida auris.
Researchers find a previously unknown way to selectively activate B cells
G-BA recommends making the Charité treatment concept available to all patients with public health insurance
Nightmares are among the most agonizing symptoms of post-traumatic stress disorder (PTSD) – a condition that can develop after exposure to severe traumatic experiences, such as disasters, serious accidents, acts of violence, or wartime experiences.…
